Health
Virus drug benefit only marginal: study – Shepparton News
Moderately ill COVID-19 patients had their condition improve after a 5-day course of Gilead Sciences Inc’s remdesivir but the drug did not significantly shorten hospital stays and a 10-day course did not show a benefit, according to new data.The drug, which was shown in a trial of severely ill COVID-19 patients to shorten their hospital recovery time, has been at the forefront of the battle against the pandemic.The 600-patient analysis, published on Friday by the Journal of the American Medical …
-
Noosa News18 hours agoReubhan Ralph identified as man behind terrifying childcare centre incident in Peregian Springs on the Sunshine Coast
-
General17 hours agoPolice say new leads being pursued after baby’s body found in Alexander Heights stormwater drain
-
General20 hours agoMan dies at shopping centre car park at Charlestown following reports of assault
-
Noosa News20 hours agoWomen’s Softball World Cup 2027 Redcliffe Brisbane